by | PRNewswire Asia
A Joyful, Design-led Partnership to Celebrate the Festive Season HONG KONG, Oct. 20, 2025 /PRNewswire/ — This festive season, 1664 is excited to announce its first-ever festive artist collaboration across Hong Kong, mainland China, Singapore, Malaysia, and...
by | PRNewswire Asia
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ — Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
by | PRNewswire Asia
– The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule...
by | PRNewswire Asia
HONG KONG, Oct. 19, 2025 /PRNewswire/ — On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase...
by | PRNewswire Asia
Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival...
by | PRNewswire Asia
KUALA LUMPUR, Malaysia and WUHU, China, Oct. 19, 2025 /PRNewswire/ — In October 2025, the OMODA&JAECOO International User Summit was grandly held to worldwide attention, with the International Technology Night becoming the highlight of the event. During...